Severe Mitral Insufficiency Following Mitral Valvotomy

Original title: Acute Severe Mitral Regurgitation Following Balloon Mitral Valvulotomy: Echocardiographic Feature, Operative Finfing and Outcome in 50 Surgical Cases. Reference: Manjunath C. Nanjappa, et al. Catherization and Cardiovascular Intervention 81:603-608 (2013)

Severe Mitral Insufficiency Following Mitral Valvotomy (VPM) is a major complication; though not frequent, (0.9%-2%) it is life threatening and requires resolution through valve replacement.

The aim of this series was to analyze the evolution of patients with acute severe mitral insufficiency following VPM. 3855 patients undergoing VPM were analyzed, 50 patients (1.3%) presented ASMR after procedure and where referred to surgery. Wilkins score was ≤8 in 23 of those 50 patients. The most frequent signs of ASMR were hypotension and hypoxia followed by orthopnea and acute pulmonary edema.

The most frequent cause of severe MR was posterior mitral leaflet tear (36 patients), it was also observe a paracommisural tear with annular involvement (7 patients), posterior mitral leaflet tear (5 patients) and chordal tear (2ptes). The time from end of procedure to replacement surgery was between 3 and 96 hrs, and 6 patients died in this period (12%).

Patients were analyzed according to the moment of surgery and were divided in 2 groups: 24 hrs (11 patients). Both groups shared similar characteristics, mortality being significantly higher in the second group (1/39 vs 5/11, p<0.001).

Conclusion: 

Hypotension and hypoxia were the most common symptoms of Severe Mitral Insufficiency Following Mitral Valvotomy and posterior mitral leaflet tear was the most frequent cause. In this scenario, early valve replacement is most recommended.

Editorial comment: 

Mitral Valvotomy is a complex procedure that presents a low complications rate but these can be severe. Clinical, hemodynamic evaluation, with eco-Doppler is essential seeing that they not only help evaluate results, they also help diagnose complications and make the correct and timely decisions. 

Courtesy of Dr. Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors such as valve hemodynamic performance, durability, and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...